Cargando…

Up-regulation of FGF15/19 signaling promotes hepatocellular carcinoma in the background of fatty liver

BACKGROUND: Upregulated fibroblast growth factor 19 (FGF19) expression in human hepatocellular carcinoma (HCC) specimens is associated with tumor progression and poor prognosis. Nonalcoholic steatohepatitis (NASH) patients are at high risk for malignant transformation into HCC. METHODS: A steatohepa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cui, Guozhen, Martin, Robert C., Jin, Hang, Liu, Xingkai, Pandit, Harshul, Zhao, Hengjun, Cai, Lu, Zhang, Ping, Li, Wei, Li, Yan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2018
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6031179/ https://www.ncbi.nlm.nih.gov/pubmed/29973237 http://dx.doi.org/10.1186/s13046-018-0781-8

Ejemplares similares

Up-regulation of fibroblast growth factor 19 and its receptor associates with progression from fatty liver to hepatocellular carcinoma
por: Li, Yan, et al.
Publicado: (2016)

Serological biomarkers associate ultrasound characteristics of steatohepatitis in mice with liver cancer
por: Cui, Guozhen, et al.
Publicado: (2018)

Lack of FGF21 promotes NASH-HCC transition via hepatocyte-TLR4-IL-17A signaling
por: Zheng, Qianqian, et al.
Publicado: (2020)

Manganese Superoxide Dismutase (MnSOD) expression is negatively associated with microRNA-301a in human Pancreatic Ductal Adenocarcinoma (PDAC)
por: Pandit, Harshul, et al.
Publicado: (2015)

Enrichment of cancer stem cells via β-catenin contributing to the tumorigenesis of hepatocellular carcinoma
por: Pandit, Harshul, et al.
Publicado: (2018)

Accumulation of Genetic and Epigenetic Alterations in the Background Liver and Emergence of Hepatocellular Carcinoma in Patients with Non-Alcoholic Fatty Liver Disease
por: Hagiwara, Satoru, et al.
Publicado: (2021)

FGF15 promotes neurogenesis and opposes FGF8 function during neocortical development
por: Borello, Ugo, et al.
Publicado: (2008)

Transgenic mice lacking FGF15/19-SHP phosphorylation display altered bile acids and gut bacteria, promoting nonalcoholic fatty liver disease
por: Kim, Young-Chae, et al.
Publicado: (2023)

Correction: FGF15 promotes neurnogenesis and opposes FGF8 function during neocortical development
por: Borello, Ugo, et al.
Publicado: (2008)

ER Stress and Autophagy Dysfunction Contribute to Fatty Liver in Diabetic Mice
por: Zhang, Quan, et al.
Publicado: (2015)

FGF9 Alleviates the Fatty Liver Phenotype by Regulating Hepatic Lipid Metabolism
por: Zhao, Fanrong, et al.
Publicado: (2022)

Is Hepatocellular Carcinoma in Fatty Liver Different to Non-Fatty Liver?
por: Nguyen, Xuan-vinh Kevin, et al.
Publicado: (2022)

New mechanisms involving the EGFR and FGF15/19 systems in liver regeneration and carcinogenesis
por: Berasain, Carmen, et al.
Publicado: (2014)

Aberrant FGFR4 signaling worsens nonalcoholic steatohepatitis in FGF21KO mice
por: Yu, Youxi, et al.
Publicado: (2021)

Carcinogenesis on the background of liver fibrosis: Implications for the management of hepatocellular cancer
por: O’Rourke, Joanne Marie, et al.
Publicado: (2018)

Probiotics Alleviated Nonalcoholic Fatty Liver Disease in High-Fat Diet-Fed Rats via Gut Microbiota/FXR/FGF15 Signaling Pathway
por: Luo, Minmin, et al.
Publicado: (2021)

miR‐149 controls non‐alcoholic fatty liver by targeting FGF‐21
por: Xiao, Junjie, et al.
Publicado: (2016)

Another Kid on the Block: Long-acting FGF21 Analogue to Treat Dyslipidemia and Fatty Liver
por: Yang, Ranyao, et al.
Publicado: (2021)

Differences in the genetic backgrounds of patients with alcoholic liver disease and non‐alcoholic fatty liver disease
por: Yamamoto, Kuniko, et al.
Publicado: (2018)

Regulation of Fgf15 expression in the intestine by glucocorticoid receptor
por: Jia, Kunzhi, et al.
Publicado: (2019)

Soluble Expression of Disulfide Bond Containing Proteins FGF15 and FGF19 in the Cytoplasm of Escherichia coli
por: Kong, Bo, et al.
Publicado: (2014)

Prognostic analysis of hepatocellular carcinoma on the background of liver cirrhosis via contrast-enhanced ultrasound and pathology
por: He, Yukai, et al.
Publicado: (2018)

FGF15 promotes hepatic NPC1L1 degradation in lithogenic diet-fed mice
por: Mo, Pingfan, et al.
Publicado: (2022)

Nonalcoholic Fatty Liver Disease and Hepatocellular Carcinoma
por: Kikuchi, Luciana, et al.
Publicado: (2014)

Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease
por: Inayat, Faisal, et al.
Publicado: (2016)

Circadian control of bile acid synthesis by a KLF15-Fgf15 axis
por: Han, Sean (Shuxin), et al.
Publicado: (2015)

RLIM suppresses hepatocellular carcinogenesis by up-regulating p15 and p21
por: Huang, Yongsheng, et al.
Publicado: (2017)

FGF15 Protects Septic Mice by Inhibiting Inflammation and Modulating Treg Responses
por: Li, Xing, et al.
Publicado: (2022)

FGF19–FGFR4 Signaling in Hepatocellular Carcinoma
por: Raja, Aroosha, et al.
Publicado: (2019)

Observations suggesting bioactive Fgf15 is not present in mouse blood
por: Rudling, Mats
Publicado: (2014)

Identification of genes in hepatocellular carcinoma induced by non-alcoholic fatty liver disease
por: Cai, Changzhou, et al.
Publicado: (2020)

Ahnak deficiency attenuates high-fat diet-induced fatty liver in mice through FGF21 induction
por: Kim, Yo Na, et al.
Publicado: (2021)

Corrigendum: Circadian control of bile acid synthesis by a KLF15-Fgf15 axis
por: Han, Shuxin, et al.
Publicado: (2015)

Development of a transgenic mouse model of hepatocellular carcinoma with a liver fibrosis background
por: Chung, Sook In, et al.
Publicado: (2016)

Altered epidermal fatty acid-binding protein expression in hepatocellular carcinoma predicts unfavorable outcomes
por: Lu, Jia-bin, et al.
Publicado: (2018)

FGF401 and vinorelbine synergistically mediate antitumor activity and vascular normalization in FGF19-dependent hepatocellular carcinoma
por: Huynh, Hung, et al.
Publicado: (2020)

Hepatocellular Carcinoma in Non-alcoholic Fatty Liver Disease: Current Progresses and Challenges
por: Teng, Yu-Xian, et al.
Publicado: (2022)

Hepatocyte-Secreted Autotaxin Exacerbates Nonalcoholic Fatty Liver Disease Through Autocrine Inhibition of the PPARα/FGF21 Axis
por: Qiu, Han, et al.
Publicado: (2022)

Surveillance of Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease
por: Sumida, Yoshio, et al.
Publicado: (2020)

S100 Proteins in Fatty Liver Disease and Hepatocellular Carcinoma
por: Delangre, Etienne, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_jcjvh9d1j4npve5tl343dkarht